...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: eGFR and Cognition?
8
Nov 22, 2019 11:47AM
10
Nov 22, 2019 12:28PM
9
Nov 22, 2019 01:10PM
2
Nov 22, 2019 01:49PM
7
Nov 22, 2019 04:05PM
1
Nov 22, 2019 04:22PM
4
Nov 22, 2019 04:38PM
16
Nov 22, 2019 04:47PM
2
Nov 22, 2019 05:10PM
5
Nov 22, 2019 05:16PM
7
Nov 22, 2019 05:21PM
2
Nov 22, 2019 05:34PM
1
Nov 22, 2019 05:58PM
3
Nov 22, 2019 06:19PM
5
Nov 22, 2019 08:14PM
1
Nov 22, 2019 10:29PM
6
Nov 22, 2019 10:48PM
6
Nov 22, 2019 11:19PM
5
Nov 22, 2019 11:43PM
1
Nov 23, 2019 07:08AM

Jonzobot,

If you are suggesting benefit in those with eGFR below 30, then you are getting into the territory of Stage 4/5 CKD, not Stage 1/2.

https://www.kidney.org/atoz/content/gfr

Resverlogix has had a planned Stage 5 End Stage Renal Disease trial in holding pattern for over 2.5 years now.

https://clinicaltrials.gov/ct2/show/NCT03160430

Additionally, Resverlogix ran a very small, very short trial in New Zealand in Stage 4/5 CKD patients and found robust changes in circulating inflammatory markers and other proteins after just 1 day of treatment. Those results are published.

https://www.ncbi.nlm.nih.gov/pubmed/29854980

BDAZ

 

4
Nov 23, 2019 07:23AM
1
Nov 23, 2019 08:05AM
3
Nov 23, 2019 09:06AM
9
Nov 23, 2019 09:24AM
4
Nov 23, 2019 09:58AM
3
Nov 23, 2019 12:31PM
4
Nov 23, 2019 03:28PM
1
Nov 23, 2019 04:31PM
3
Nov 23, 2019 04:49PM
5
Nov 23, 2019 05:09PM
6
Nov 23, 2019 06:16PM
4
Nov 23, 2019 06:55PM
5
Nov 23, 2019 06:59PM
2
Nov 23, 2019 07:11PM
9
Nov 23, 2019 08:15PM
6
Nov 23, 2019 09:19PM
4
Nov 25, 2019 01:39AM
3
Nov 25, 2019 02:14AM
2
Nov 25, 2019 02:16AM
5
Nov 25, 2019 02:40AM
2
Nov 25, 2019 02:48AM
1
Nov 25, 2019 08:03AM
5
Nov 25, 2019 09:17AM
3
Nov 25, 2019 10:20AM
5
Nov 25, 2019 02:39PM
Share
New Message
Please login to post a reply